Skip to main content

Characterization of Arcobacter strains isolated from human stool samples: results from the prospective German prevalence study Arcopath



Arcobacter constitute emerging food- and waterborne pathogens causing gastroenteritis in humans, but the underlying mechanisms are only incompletely understood. We therefore characterized Arcobacter isolates derived from human stool samples that had been collected during a prospective prevalence study in Germany in vitro. Thirty-six bacterial isolates belonging to the species A. butzleri (n = 24), A. cryaerophilus (n = 10) and A. lanthieri (n = 2) were genotyped by ERIC-PCR, the presence of 10 putative virulence genes was assessed and cytotoxic effects on the human intestinal cell line HT-29/B6 were analyzed applying the WST-assay.


Genotyping revealed high genetic diversity within the species A. butzleri, A. cryaerophilus and A. lanthieri. Both, A. butzleri and A. lanthieri encoded for a large number of putative virulence genes, while fewer genes were detectable in A. cryaerophilus isolates. Notably, the three cytolethal distending toxin (CDT) genes cdtA, cdtB and cdtC were abundant in both A. lanthieri isolates. Furthermore, all A. butzleri and A. lanthieri, but only one of the A. cryaerophilus isolates exerted cytotoxic effects.


Our study provides evidence for the abundance of putative virulence genes in Arcobacter isolates and prominent cytotoxic effects of A. butzleri and A. lanthieri in vitro. The presence of cdtA, cdtB, cdtC in A. lanthieri points towards CDT secretion as potential mechanism underlying cytotoxicity as opposed to A. butzleri. However, the association of the Arcobacter virulence factors detected and human morbidity should be addressed in future studies.


Arcobacter constitute Gram-negative, motile bacilli belonging to the class of Epsilonproteobacteria, with 29 different species described so far [1]. In contrast to the genus Campylobacter, Arcobacter species are mostly aerotolerant and able to grow at temperatures below 30 °C [2]. Arcobacter have been isolated from different environmental sources, such as animals, food of animal origin, vegetables and surface water [3,4,5]. In animals, Arcobacter are mostly described as commensals but symptoms of infection like enteritis and mastitis have been reported [5]. In humans, Arcobacter infections are associated with gastroenteritis characterized by prolonged watery diarrhea and abdominal cramps, while single cases of bacteremia have been described [3, 6, 7]. Since 2002, the Arcobacter species A. butzleri and A. cryaerophilus have been classified as “serious hazard to human health” by the International Commission on Microbiological Specification for Foods [8]. However, both, the prevalence and significance of Arcobacter infections in humans are most likely underestimated, given the lack of standardized isolation procedures.

When assessing the potential pathomechanisms underlying Arcobacter induced disease, several studies revealed adhesive, invasive and cytotoxic properties of Arcobacter spp., with slightly different conclusions depending on the strains investigated, cell lines included and methods applied [3, 5, 9,10,11,12,13]. A. butzleri have been shown to compromize the barrier function in epithelial monolayers of HT-29/B6 cells in vitro, a mechanism, which might be responsible for the diarrhea induced by Arcobacter spp.[14]. However, the relevant virulence factors of Arcobacter spp. are yet to be identified. Within the whole genome sequence of A. butzleri RM4018, the ten putative virulence factors cadF, cj1349, ciaB, pldA, tlyA, mviN, hecA, hecB, irgA and iroE have been determined, known to be involved in the pathogenicity of other bacteria [15]. So far, no correlation between the occurrence of the respective putative virulence genes in Arcobacter and their pathogenic potential could be unraveled. Furthermore, no toxin, which might be responsible for the cytotoxic effects reported for A. butzleri, has been identified yet. In contrast to A. butzleri and A. cryaerophilus, the cytolethal distending toxin (CDT) encoding genes cdtABC have been detected in several A. lanthieri isolates [16].

In a very recent prospective human prevalence study in Germany, we surveyed almost 4700 stool samples for the prevalence of Arcobacter. The stool samples had been collected at three microbiological diagnostic laboratories in Berlin, Germany, and were submitted for the detection of bacterial enteropathogens. Among the detected Arcobacter, A. butzleri was the most prevalent species, followed by A. cryaerophilus and A. lanthieri (GUTP-D-19-00199).

The aim of present study was to characterize the 36 Arcobacter isolates derived from the above mentioned human prevalence study in terms of their (i) genotype, (ii) presence of virulence genes and (iii) cytotoxic potential in vitro.


Genotyping of Arcobacter isolates

Enterobacterial repetitive intergenic consensus (ERIC) sequences were detected in all 36 Arcobacter isolates, and different fragment patterns were generated consisting of 5 to 15 fragments ranging from approximately 100–1000 bp in length. For analysis of fragment patterns, the similarities were calculated using Dice coefficient followed by the Unweighted Pair Group Method with Arithmetic mean (UPGMA) to generate a dendrogram, showing the level of genetic similarity (Fig. 1). Dendrogram analyses revealed a high genetic diversity, particularly among the A. cryaerophilus isolates. Only the A. butzleri isolates were clustering in one large group with 60% similarity. This cluster also included three independent replicates of the human A. butzleri reference strain (CCUG30485) with identical fragment pattern, indicating the reproducibility of the method applied. Interestingly, also three A. cryaerophilus isolates were included in this cluster. In fact, no species-specific cluster could be identified for isolates of A. cryaerophilus, while both A. lanthieri isolates were clustering at a high similarity level (86%).

Fig. 1

Dendrogram based on ERIC-PCR assay using Dice similarity coefficient and UPGMA method and virulence gene pattern of Arcobacter spp. isolated from human stool samples. Black: genes detected by primers designed based on A. butzleri sequences (Douidah et al. [25], Karadas et al. [11], Whiteduck-Leveillee et al. [40]; pale grey: genes not detected by both PCR; dark grey: genes detected by primers designed based on A. lanthieri sequences (Zambri et al. [16]). A. butzleri (CCUG 30485) was included as reference strain

Abundance of putative virulence genes

Additionally, we analyzed the presence of the ten putative virulence genes described for A. butzleri [15]. A majority of these putative virulence genes were detected in A. butzleri, while considerably fewer genes were assessed in A. cryaerophilus (Fig. 1). In fact, the genes ciaB, cj1349, cadF, and tlyA were present in all A. butzleri (n = 24) isolates, whereas pldA, mviN, hecB, and hecA were detectable in 96%, 83%, 29%, and 25% of the isolates, respectively. In contrast, the genes iroE and irgA were less frequently detected, namely in 12% (n = 3) and 8% (n = 2) of the isolates, respectively. Among the ten A. cryaerophilus strains, ciaB was present in all isolates, while the mviN, cadF and pldA genes were detectable in eight, four and two isolates, respectively. Two further genes, namely tlyA and irgA, were each detected in a single A. cryaerophilus isolate.

When using A. butzleri-specific PCR-primers, only the presence of hecB could be assessed in both A. lanthieri strains, whereas ciaB, mviN, cadF, pldA, tlyA, and irgA were only detected by using the A. lanthieri-specific primers. Furthermore, the three genes encoding for the CDT, i.e., cdtA, cdtB, and cdtC, were present in both A. lanthieri strains (data not shown).

Cytotoxic effects in vitro

Finally, we assessed potential cytotoxic effects of the isolated Arcobacter isolates in vitro by using the human intestinal cell line HT-29/B6. HT-29/B6 cells were incubated for 48 h at 37 °C with the Arcobacter isolates (MOI of 100). Cytotoxicity was determined by measuring the residual viability of HT-29/B6 cells in the colorimetric WST-assay. Inoculation with the human isolate A. cryaerophilus (ILSH 02659), which was included as negative control, revealed no significant changes in absorbance compared to uninfected media control (10%) indicating that most cells remained metabolically active. Inoculation with all A. butzleri strains, both outpatient and in-clinic isolates, however, resulted in a significant reduction of absorbance compared to media control, indicative for significant cytotoxic effects on HT-29/B6 cells (Fig. 2a). Fourteen isolates were identified as high cytotoxic strains (Group III), causing a decrease in absorbance by at least 95% compared to control, which was comparable to the reductions induced by the positive controls, C. jejuni 81–176 (97%) and DMSO (105%), respectively. Absorbances measured after inoculation with another nine isolates were significantly reduced by 50% to 95% compared to control, indicative for moderate cytotoxicity (Group II). In contrast to all other A. butzleri isolates, only strain 02754 induced a smaller decrease in absorbance by 32%, demonstrating relatively low cytotoxic activity (Group I).

Fig. 2

Viability of HT-29/B6 cells after inoculation with Arcobacter isolates. HT-29/B6 cells, differentiated for 7 days, were inoculated with A. butzleri (a), A. cryaerophilus (b) and A. lanthieri (c) isolates (MOI 100, except for isolates 02651 and 02771 that were incubated at MOI 50), and cytotoxicity was measured after 48 h incubation by WST-1 assay. At least three independent experiments were performed with six replicates each. Cells treated with medium only or with A. cryaerophilus ILSH 02659 (Ac) were included as negative control, and dimethyl sulfoxide (DMSO) and Campylobacter jejuni 81–176 (Cj) as positive controls. The isolates were arbitrarily classified in three groups due to the level of toxicity, i.e., isolates of low (group I), moderate (group II) and high cytotoxicity (group III) with 20–49%, 50–94% and at least 95% reduction of absorbance as compared to the negative control, respectively. # inoculation at MOI 50; * p < 0.05 (Mann–Whitney U-test) as compared to control

In contrast to A. butzleri, the majority of the investigated A. cryaerophilus isolates (8 out of 10) did not induce cytotoxic effects on HT-29/B6 cells. Due to limited bacterial growth, however, the inoculation with isolates 02651 and 02771 had to be performed at MOI 50 instead of MOI 100; hence, respective results should be interpreted with caution. The inoculation with these isolates resulted in absorbances that were not significantly different from media control (Fig. 2b). Only isolates 02657 and 02771 exerted a significant reduction of absorbance by 29% and 20%, respectively, as compared to control, pointing towards some cytotoxic activity (Group I).

Both A. lanthieri isolates induced high cytotoxicity (Group III) in HT-29/B6 cells, yielding a reduction of absorbance by at least 96%, that was comparable to C. jejuni and DMSO control (Fig. 2c).



Various reports using ERIC-PCR to unravel the genetic diversity of Arcobacter have described a large heterogeneity among this bacterial genus [17,18,19]. Likewise, Mandisodza et al. [7] described 12 different pulsotypes using pulsed field gel electrophoresis among 7 A. butzleri and 5 A. cryaerophilus strains from human diarrheal cases. These findings are in agreement with our data; in fact, we here observed a unique genotype for each isolate. While dendrogram analysis revealed species-specific cluster for most A. butzleri and both A. lanthieri strains, A. cryaerophilus isolates were widely distributed within the dendrogram. Based on genomic comparisons, a recently published study has suggested to subdivide the species A. cryaerophilus into four separate genomovars [20] which might explain the high heterogeneity of the A. cryaerophilus detected in our survey.

Houf et al. [21] have reported 91 genotypes of A. butzleri out of 182 isolates and 40 genotypes of A. cryaerophilus out of 42 isolates obtained from poultry products, and 91.2% of the isolates obtained from sewage effluent showed different fragment patterns [22]. Importantly, the different genotypes are not associated with the source of the isolates [23]. However, Sekhar et al. [24] have recently shown genetic similarity of isolates from animal and human origin determined by rep-PCR cluster analysis, indicating the possibility of zoonotic transmission. Further investigations are necessary to identify distinct sources of infection and transmission routes of Arcobacter.

Virulence genes

Our study revealed the abundance of ten putative virulence genes with homologies to virulence factors of other bacteria, particularly C. jejuni. In agreement with our data, six of these genes, i.e., ciaB, cj1349, cadF, tlyA, pldA, and mviN, have been detected most frequently in A. butzleri strains isolated from various sources, with prevalences ranging from 66 to 100% [11, 23, 25,26,27,28,29,30,31]. We found hecB, hecA and irgA less frequently and at lower rates as compared to other reports [11, 23, 25, 27, 29, 31, 32]. The least frequently detected gene in our survey was irgA, which is in line with other studies [11, 26, 27, 33], although irgA rates of 25–46% have also been reported [23, 25, 29, 31]. The presence of iroE has rarely been investigated with prevalences of 17–60% [11, 23, 26, 27], which is slightly higher than the detected 13% in our study. Nevertheless, considering all studies published hecB, hecA, irgA, and iroE appear to be less common in A. butzleri. In summary, in none of the A. butzleri isolates, we detected all of the putative virulence genes investigated. This difference to other studies describing 10–23% of the strains derived from different sources to possess all of the analyzed genes may be due to the different sources of the bacterial isolates [11, 23, 26, 27], since we investigated exclusively human isolates.

Overall, we identified less virulence genes in A. cryaerophilus than in A. butzleri. While ciaB was detected in all A. cryaerophilus isolates, the genes mviN, cadF, and pldA were found in 80%, 40%, and 20% of isolates, respectively, and tlyA as well as irgA in 10% of isolates. The ciaB and mviN genes have previously been reported to be more abundant than other putative virulence genes in A. cryaerophilus [11, 23, 25, 29, 31], and also our data regarding the detection of tlyA and pldA are in line with these studies. Furthermore, we detected cadF in 40% of isolates, which is in concordance with other studies reporting the presence of cadF in 10–62% of isolates [25, 26, 28,29,30]. While we were not able to detect any further virulence genes in A. cryaerophilus, other studies have reported the presence of cj1349 in 20–77% of isolates [25, 26, 28,29,30], and also the genes hecB, hecA, and irgA were identified more often than in our study [25]. These differences might be due to the genomic heterogeneity in primer binding sequences.

When analyzing the virulence genes of A. lanthieri the use of A. butzleri specific primers allowed the detection of only hecB in both A. lanthieri isolates, whereas applying the species-specific primer revealed six additional genes. Based on this, A. lanthieri displays a similar virulence gene pattern as A. butzleri. We also detected more virulence genes in A. cryaerophilus by the primers designed on the base of A. lanthieri than of A. butzleri sequences. This underlines the need of genus-specific primers for the detection of virulence genes in Arcobacter, which needs to be addressed in future studies. Furthermore, we detected the cdtA, cdtB, and cdtC genes encoding for CDT in both A. lanthieri isolates, which are also expressed by several C. jejuni strains [34] and likely contribute to their pathogenicity [35, 36].

Cytotoxic effects

In addition, we addressed cytotoxic properties of the isolates in vitro by using the WST-1 assay. Our results indicate moderate to high levels of cytotoxicity for most A. butzleri isolates, which is in agreement with a previous study where cytotoxicity also was determined by measuring the activity of mitochondrial dehydrogenases [10]. In contrast, other studies assessed the cytotoxic effects by microscopical examination [9, 37, 38], and observed cytotoxic effects of broth culture filtrates of A. butzleri on Vero and CHO cells. Besides secretion of an enterotoxin, the production of a vacuolizing toxin-like factor has been postulated [13].

Cytotoxicity of A. cryaerophilus has rather rarely been demonstrated [13, 39]. This discrepancy to our findings might be due to the different methods, cell lines or strains used. Furthermore, our study is the first one assessing cytotoxic activity of A. lanthieri isolates derived from human stool specimens, and both isolates exhibited a high degree of cytotoxicity. Still, this finding needs to be confirmed by analyzing larger number of isolates.

It yet remains unclear, which gene(s) might be involved in exerting the cytotoxic effects. In A. butzleri, however, a toxin different to CDT is assumed to be encoded [34], since genome sequencing of the reference strain A. butzleri RM1408 [15] and also of selected A. butzleri strains investigated by us revealed the absence of CDT genes. This is further supported by cytotoxicity of CDT-negative Arcobacter [39]. Notably, we here detected all three CDT toxin genes in both A. lanthieri isolates, which is in concordance with results from Zambri et al. [16], who detected these in 8 out of 11 A. lanthieri isolates from various environmental and fecal sources. Thus, while CDT may likely be involved in A. lanthieri-induced cytotoxicity, other factors might contribute to cytotoxic effects of A. butzleri. For example, the two putative virulence genes cj1349 and tlyA were present in all A. butzleri and A. lanthieri isolates, displaying cytotoxic effects on HT-29/B6 cells. In other bacterial species, cj1349 has been shown to be associated with the adhesion to intestinal cells and tlyA with hemolysis of erythrocytes. In a recent study of Karadas et al. [10] six A. butzleri isolates, all encoding for the adhesion gene cj1349, displayed differently prominent adhesive phenotypes, whereas no correlation between the adhesive phenotypes and respective amino acid sequences could be shown, however. Furthermore, two isolates exerting only low or no adhesive capacities at all were even highly cytotoxic [11]. Therefore, based upon our obtained results it appears rather difficult to draw definite conclusions whether cj1349 is involved in the capacity of Arcobacter spp. exerting cytotoxicity, whereas tlyA might represent a putative virulence factor, which needs, however, to be further investigated in this regard.


In this study, characterization of human Arcobacter isolates revealed an abundance of putative virulence genes and prominent in vitro cytotoxic effects of A. butzleri and A. lanthieri. Furthermore, the presence of cdtA, cdtB, and cdtC in A. lanthieri, but not in A. butzleri indicates that CDT production might contribute to cytotoxicity exerted by A. lanthieri. Further studies are warranted for further in-depth evaluation of the role of Arcobacter in human disease.


Bacterial strains and culture conditions

A total of 36 human Arcobacter isolates (24 A. butzleri, 10 A. cryaerophilus and 2 A. lanthieri) and the reference strain A. butzleri (CCUG 30485) were included. The 36 human isolates were collected during a previous prospective Arcobacter prevalence study in Germany by using selective enrichment media, and species verified by multiplex PCR and rpoB sequencing (GUTP-D-19-00199). All incubation steps were performed at 30 °C in Brucella broth (BB; BD, Heidelberg, Germany) or on Mueller–Hinton agar plates (Oxoid) supplemented with 5% sheep blood (MHB) under microaerobic conditions unless stated differently.

Genotyping by ERIC-PCR

For evaluating genetic diversity the identified isolates were characterized by ERIC-PCR as previously described [21]. For amplification of the intergenic sequences between the ERIC-sequences the ERIC motifs 1R and 2 were used (Table 1). The PCR reaction mixture contained 1 × PCR buffer (Qiagen, Venlo, Netherlands), 4 mM MgCl2 (Qiagen), 0.2 mM of each deoxynucleoside triphosphate (dNTP; Thermo Fisher Scientific, Waltham, USA), 2.5 U Taq polymerase (Qiagen), 0.5 µM of each primer and 1 µl template DNA in a total reaction volume of 25 µl. PCR samples were subjected to an initial denaturation at 94 °C for 5 min, followed by 40 amplification cycles, consisting of denaturation at 94 °C for 1 min, annealing at 25 °C for 1 min and elongation at 72 °C for 2 min, and subsequently 5 min at 72 °C for final extension. Amplified products were separated using gel electrophoresis and visualized under UV light by GRgreen staining. Analyses of respective fragment patterns were performed by using BioNumerics version 7.1 (Applied Maths, Sint- Martens-Latem, Belgium). The similarities between profiles were calculated using Dice coefficient, and the UPGMA method was used for cluster analysis and to generate dendrograms.

Table 1 List of primers used in this study

Presence of virulence associated genes

All primers used are listed in Table 1. PCR protocols for partial amplification of ciaB, mviN, pldA, tlyA, irgA, hecA, hecB and cj1349 were used according to Whiteduck-Leveillee et al. [40]. Briefly, 25 µl PCR-mixture contained 2 µl template DNA, 1 × PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.5 U Taq polymerase and 0.1 µM of corresponding primers. Reaction conditions were 95 °C for 4 min followed by 30 cycles of 95 °C for 30 s, 56 °C for 45 s and 72 °C for 45 s and ended with a final extension step at 72 °C for 5 min. Partial amplification of iroE and cadF was carried out according to the protocol of Karadas et al. [11]. The PCR-mixture contained the same composition as described above except for the primers being at 1 µM. Reaction conditions were 95 °C for 4 min followed by 30 cycles of 95 °C for 30 s, 50 °C for 30 s and 72 °C for 30 s and ended with a final extension step at 72 °C for 5 min.

For analysis of A. lanthieri additional primers and a protocol described by Zambri et al. [16] were used for the detection of ciaB, mviN, cadF, pldA, tlyA, irgA, cdtA, cdtB and cdtC. Briefly, 25 µl PCR-mixture contained 2 µl template DNA, 1 × PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 0.5 U Taq polymerase and different concentrations of corresponding primers (0.4 µM of each AL_cdtB, AL_cadF, AL_irgA, and AL_mviN; 0.3 µM of each AL_cdtC and AL_cdtA; 0.2 µM of each AL_ciaB; 0.1 µM of each AL_pldA and AL_tlyA). Reaction conditions were 94 °C for 2 min followed by 35 cycles of 95 °C for 30 s, primer specific annealing temperatures for 45 s (56 °C for cdtB, cadF, irgA; 57 °C for cdtC, pldA; 55 °C for cdtA, mviN; 60 °C for ciaB, tlyA) and 72 °C for 30 s and ended with a final extension step at 72 °C for 5 min. Amplified products were separated using gel electrophoresis and visualized under UV light by GRgreen staining.

Cell culture

The human colon adenocarcinoma cell line HT-29/B6 [41] was grown in a 75 cm2 tissue culture flask (Sarstedt, Nümbrecht, Germany) containing RPMI1640 medium (Lonza Bioscience, Cologne, Germany) supplemented with 10% fetal bovine serum (FBS) (Lonza Bioscience) and 10 µg/ml gentamicin (Biochrom, Berlin, Germany) at 37 °C in a 5% CO2 humidified atmosphere.

Cytotoxicity analysis

The WST-assay (as described by Karadas et al. [10]) was used to assess cytotoxic effects of Arcobacter isolates on the human intestinal cell line, HT-29/B6. This colorimetric assay is based on enzymatic conversion of tetrazolium salt WST-1 (4-[3-(4-Iodophenyl)-2-(4-nitro-phenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) to formazan by cellular mitochondrial dehydrogenases, present in viable cells, resulting in a color change from red to orange. The measured absorbance directly correlates with the number of metabolically active cells and therefore, also reflects cytotoxic effects indicated by a decrease in cell proliferation.

HT-29/B6 cells were seeded in 96-well-plates (Sarstedt) at a density of 3 × 104 cells/well (100 µl each well). After differentiation for 7 days at 37 °C in a humidified incubator with 5% CO2, cells were washed with phosphate-buffered saline (PBS, Sigma-Aldrich) and antibiotic-free medium was added prior to Arcobacter-treatment.

Arcobacter isolates were precultured overnight in BB. The precultures were diluted 1:100 in 10 ml BB and further incubated overnight. The overnight cultures were centrifuged at 5000×g for 10 min and pellets resuspended in 1 ml PBS resulting in approximately 1 × 108 CFU in the inoculum volume of 50 µl. To receive similar concentrations for A. cryaerophilus isolates, due to slower growth, three overnight cultures of each isolate were prepared in BB and incubated for 48 h. After centrifugation of pooled cultures, pellets were resuspended in 600 µl PBS. C. jejuni (81–176) was used as reference strain and processed as described but at 37 °C.

Prepared bacterial inocula (50 µl) were added to HT-29/B6 cells in 96-well plate with a multiplicity of infection (MOI) of 100 and incubated for 48 h at 37 °C with 5% CO2. As negative controls, cells were treated with medium only or with A. cryaerophilus (ILSH 02659), a strain without cytotoxic effect in this assay. As positive controls, dimethyl sulfoxide (DMSO) and C. jejuni (81–176) were used. The WST-1 cell proliferation assay kit (Roche Applied Science, Mannheim, Germany) was used according to the manufacturer’s instructions. Briefly, the wells were washed once with PBS before adding 110 µl WST-1-reagent to each well. After 1 h incubation (37 °C, 5% CO2) 100 µl of the supernatant were transferred to a new 96-well plate prior to measuring the absorbance of the formazan product at 450 nm using a microplate reader (FLUOstar OPTIMA; BMG Labtech, Ortenberg, Germany). The obtained data were corrected by subtracting the reagent blank from each of the other determined values. At least three independent experiments were performed with six replicates each. The level of toxicity was arbitrarily classified, i.e., high, moderate and low cytotoxicity characterized by at least 95%, 50–94% and 20–49% reduction of absorbance as compared to uninfected media control, respectively.

Statistical analyses

For each isolate at least three independent experiments were performed with six replicates each, and data analyzed by using GraphPad Prism (version 5.04; GraphPad Software, Inc., La Jolla, US). The nonparametric two-tailed Mann–Whitney U Test was used to calculate significant differences in cytotoxic effects of Arcobacter isolates. Two-sided probability (p) values ≤ 0.05 were considered significant.

Availability of data and materials

All data generated or analysed during this study are included in this published article.


  1. 1.

    Perez-Cataluna A, Salas-Masso N, Dieguez AL, Balboa S, Lema A, Romalde JL, et al. Revisiting the taxonomy of the genus Arcobacter: getting order from the chaos. Front Microbiol. 2018;9:2077.

    Article  Google Scholar 

  2. 2.

    Vandamme P, Falsen E, Rossau R, Hoste B, Segers P, Tytgat R, et al. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol. 1991;41(1):88–103.

    CAS  Article  Google Scholar 

  3. 3.

    Ferreira S, Queiroz JA, Oleastro M, Domingues FC. Insights in the pathogenesis and resistance of Arcobacter: a review. Crit Rev Microbiol. 2016;42(3):364–83.

    CAS  PubMed  Google Scholar 

  4. 4.

    Hsu TTD, Lee J. Global distribution and prevalence of Arcobacter in food and water. Zoonoses Public Health. 2015;62(8):579–89.

    Article  Google Scholar 

  5. 5.

    Ramees TP, Dhama K, Karthik K, Rathore RS, Kumar A, Saminathan M, et al. Arcobacter: an emerging food-borne zoonotic pathogen, its public health concerns and advances in diagnosis and control - a comprehensive review. Vet Q. 2017;37(1):136–61.

    Article  Google Scholar 

  6. 6.

    Figueras MJ, Levican A, Pujol I, Ballester F, Rabada Quilez MJ, Gomez-Bertomeu F. A severe case of persistent diarrhoea associated with Arcobacter cryaerophilus but attributed to Campylobacter sp. and a review of the clinical incidence of Arcobacter spp. New Microb New Infect. 2014;2(2):31–7.

    CAS  Article  Google Scholar 

  7. 7.

    Mandisodza O, Burrows E, Nulsen M. Arcobacter species in diarrhoeal faeces from humans in New Zealand. N Z Med J. 2012;125(1353):40–6.

    PubMed  Google Scholar 

  8. 8.

    ICMSF ICoMSfF. In: Tompkin RB (ed), Microbiological testing in food safety management, vol 7. New York: Kluwer Academic/Plenum Publishers; 2002, p. 171

  9. 9.

    Carbone M, Maugeri TL, Giannone M, Gugliandolo C, Midiri A, Fera MT. Adherence of environmental Arcobacter butzleri and Vibrio spp. isolates to epithelial cells in vitro. Food Microbiol. 2003;20(5):611–6.

    Article  Google Scholar 

  10. 10.

    Karadas G, Bucker R, Sharbati S, Schulzke JD, Alter T, Golz G. Arcobacter butzleri isolates exhibit pathogenic potential in intestinal epithelial cell models. J Appl Microbiol. 2016;120(1):218–25.

    CAS  Article  Google Scholar 

  11. 11.

    Karadas G, Sharbati S, Hanel I, Messelhausser U, Glocker E, Alter T, et al. Presence of virulence genes, adhesion and invasion of Arcobacter butzleri. J Appl Microbiol. 2013;115(2):583–90.

    CAS  Article  Google Scholar 

  12. 12.

    Levican A, Alkeskas A, Gunter C, Forsythe SJ, Figueras MJ. Adherence to and invasion of human intestinal cells by Arcobacter species and their virulence genotypes. Appl Environ Microb. 2013;79(16):4951–7.

    CAS  Article  Google Scholar 

  13. 13.

    Villarruel-Lopez A, Marquez-Gonzalez M, Garay-Martinez LE, Zepeda H, Castillo A, Mota de la Garza L, et al. Isolation of Arcobacter spp. from retail meats and cytotoxic effects of isolates against vero cells. J Food Prot. 2003;66(8):1374–8.

    CAS  Article  Google Scholar 

  14. 14.

    Bücker R, Troeger H, Kleer J, Fromm M, Schulzke JD. Arcobacter butzleri induces barrier dysfunction in intestinal HT-29/B6 cells. J Infect Dis. 2009;200(5):756–64.

    Article  Google Scholar 

  15. 15.

    Miller WG, Parker CT, Rubenfield M, Mendz GL, Wosten MM, Ussery DW, et al. The complete genome sequence and analysis of the epsilon proteobacterium Arcobacter butzleri. PLoS ONE. 2007;2(12):e1358.

    Article  Google Scholar 

  16. 16.

    Zambri M, Cloutier M, Adam Z, Lapen DR, Wilkes G, Sunohara M, et al. Novel virulence, antibiotic resistance and toxin gene-specific PCR-based assays for rapid pathogenicity assessment of Arcobacter faecis and Arcobacter lanthieri. BMC Microbiol. 2019;19(1):11.

    Article  Google Scholar 

  17. 17.

    Houf K, Devriese LA, Haesebrouck F, Vandenberg O, Butzler JP, Van Hoof J, et al. Antimicrobial susceptibility patterns of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from humans and broilers. Microb Drug Resist. 2004;10(3):243–7.

    CAS  Article  Google Scholar 

  18. 18.

    Houf K, Stephan R. Isolation and characterization of the emerging foodborn pathogen Arcobacter from human stool. J Microbiol Meth. 2007;68(2):408–13.

    CAS  Article  Google Scholar 

  19. 19.

    Kayman T, Abay S, Hizlisoy H, Atabay HI, Diker KS, Aydin F. Emerging pathogen Arcobacter spp. in acute gastroenteritis: molecular identification, antibiotic susceptibilities and genotyping of the isolated arcobacters. J Med Microbiol. 2012;61(Pt 10):1439–44.

    CAS  Article  Google Scholar 

  20. 20.

    Perez-Cataluna A, Collado L, Salgado O, Lefinanco V, Figueras MJ. A polyphasic and taxogenomic evaluation uncovers Arcobacter cryaerophilus as a species complex that embraces four genomovars. Front Microbiol. 2018;9:805.

    Article  Google Scholar 

  21. 21.

    Houf K, De Zutter L, Van Hoof J, Vandamme P. Assessment of the genetic diversity among arcobacters isolated from poultry products by using two PCR-based typing methods. Appl Environ Microb. 2002;68(5):2172–8.

    CAS  Article  Google Scholar 

  22. 22.

    Collado L, Kasimir G, Perez U, Bosch A, Pinto R, Saucedo G, et al. Occurrence and diversity of Arcobacter spp. along the Llobregat River catchment, at sewage effluents and in a drinking water treatment plant. Water Res. 2010;44(12):3696–702.

    CAS  Article  Google Scholar 

  23. 23.

    Lehmann D, Alter T, Lehmann L, Uherkova S, Seidler T, Golz G. Prevalence, virulence gene distribution and genetic diversity of Arcobacter in food samples in Germany. Berl Munch Tierarztl Wochenschr. 2015;128(3–4):163–8.

    PubMed  Google Scholar 

  24. 24.

    Sekhar MS, Rao TS, Chinnam BK, Subramanyam KV, Metta M, Sharif NM. Genetic Diversity of Arcobacter Species of Animal and Human Origin in Andhra Pradesh India. Indian J Microbiol. 2017;57(2):250–2.

    Article  Google Scholar 

  25. 25.

    Douidah L, de Zutter L, Bare J, De Vos P, Vandamme P, Vandenberg O, et al. Occurrence of putative virulence genes in arcobacter species isolated from humans and animals. J Clin Microbiol. 2012;50(3):735–41.

    CAS  Article  Google Scholar 

  26. 26.

    Girbau C, Guerra C, Martinez-Malaxetxebarria I, Alonso R, Fernandez-Astorga A. Prevalence of ten putative virulence genes in the emerging foodborne pathogen Arcobacter isolated from food products. Food Microbiol. 2015;52:146–9.

    CAS  Article  Google Scholar 

  27. 27.

    Piva S, Gariano GR, Bonilauri P, Giacometti F, Decastelli L, Florio D, et al. Occurrence of putative virulence genes on Arcobacter butzleri isolated from three different environmental sites throughout the dairy chain. J Appl Microbiol. 2017;122(4):1071–7.

    CAS  Article  Google Scholar 

  28. 28.

    Sekhar MS, Tumati SR, Chinnam BK, Kothapalli VS, Sharif NM. Virulence gene profiles of Arcobacter species isolated from animals, foods of animal origin, and humans in Andhra Pradesh India. Vet World. 2017;10(6):716–20.

    Article  Google Scholar 

  29. 29.

    Silha D, Vackova B, Silhova L. Occurrence of virulence-associated genes in Arcobacter butzleri and Arcobacter cryaerophilus isolates from foodstuff, water, and clinical samples within the Czech Republic. Folia Microbiol. 2019;64(1):25–31.

    CAS  Article  Google Scholar 

  30. 30.

    Tabatabaei M, Shirzad Aski H, Shayegh H, Khoshbakht R. Occurrence of six virulence-associated genes in Arcobacter species isolated from various sources in Shiraz Southern Iran. Microb Pathog. 2014;66:1–4.

    CAS  Article  Google Scholar 

  31. 31.

    Zacharow I, Bystron J, Walecka-Zacharska E, Podkowik M, Bania J. Genetic diversity and incidence of virulence-associated genes of Arcobacter butzleri and Arcobacter cryaerophilus isolates from Pork, Beef, and Chicken Meat in Poland. Biomed Res Int. 2015;2015:956507.

    Article  Google Scholar 

  32. 32.

    Abdelbaqi K, Menard A, Prouzet-Mauleon V, Bringaud F, Lehours P, Megraud F. Nucleotide sequence of the gyrA gene of Arcobacter species and characterization of human ciprofloxacin-resistant clinical isolates. Fems Immunol Med Microbiol. 2007;49(3):337–45.

    CAS  Article  Google Scholar 

  33. 33.

    Perez-Cataluna A, Tapiol J, Benavent C, Sarvise C, Gomez F, Martinez B, et al. Antimicrobial susceptibility, virulence potential and sequence types associated with Arcobacter strains recovered from human faeces. J Med Microbiol. 2017;66(12):1736–43.

    CAS  Article  Google Scholar 

  34. 34.

    Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog. 1988;4(2):115–26.

    CAS  Article  Google Scholar 

  35. 35.

    Pickett CL, Pesci EC, Cottle DL, Russell G, Erdem AN, Zeytin H. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campsssylobacter sp. cdtB gene. Infect Immun. 1996;64(6):2070–8.

    CAS  Article  Google Scholar 

  36. 36.

    Zheng J, Meng J, Zhao S, Singh R, Song W. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect Immun. 2008;76(10):4498–508.

    CAS  Article  Google Scholar 

  37. 37.

    Gugliandolo C, Irrera GP, Lentini V, Maugeri TL. Pathogenic Vibrio, Aeromonas and Arcobacter spp. associated with copepods in the Straits of Messina (Italy). Mar Pollut Bull. 2008;56(3):600–6.

    CAS  Article  Google Scholar 

  38. 38.

    Musmanno RA, Russi M, Lior H, Figura N. In vitro virulence factors of Arcobacter butzleri strains isolated from superficial water samples. New Microbiol. 1997;20(1):63–8.

    CAS  PubMed  Google Scholar 

  39. 39.

    Johnson LG, Murano EA. Lack of a cytolethal distending toxin among Arcobacter isolates from various sources. J Food Protect. 2002;65(11):1789–95.

    CAS  Article  Google Scholar 

  40. 40.

    Whiteduck-Leveillee J, Cloutier M, Topp E, Lapen DR, Talbot G, Villemur R, et al. Development and evaluation of multiplex PCR assays for rapid detection of virulence-associated genes in Arcobacter species. J Microbiol Methods. 2016;121:59–655.

    CAS  Article  Google Scholar 

  41. 41.

    Kreusel KM, Fromm M, Schulzke JD, Hegel U. Cl- secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6). Am J Physiol. 1991;261(4 Pt 1):C574–C582582.

    CAS  Article  Google Scholar 

Download references


Not applicable.


This work was supported from the German Federal Ministries of Education and Research (BMBF) by grant 01Kl1712 (Arco-Path). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Author information




VB: Performed experiments, analyzed data, wrote paper. UF: Performed experiments, analyzed data, co-edited paper. RI: Provided advice in study design, critically discussed results, co-edited paper. JF: Provided advice in study design, critically discussed results, co-edited paper. ME: Provided advice in study design, critically discussed results, co-edited paper. MH: Provided advice in study design, critically discussed results, co-edited paper. TA: Provided advice in study design, critically discussed results, co-edited paper. SB: Provided advice in study design, critically discussed results, co-edited paper. MMH: Designed study, co-wrote paper. GG: Designed study, performed experiments, analyzed data, co-wrote paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Greta Gölz.

Ethics declarations

Ethics approval and consent to participate

The study was performed in accordance with the General Data Protection Regulation of the European Union. Since the collected Arcobacter isolates were collected in routine stool analyses for the presence of bacterial pathogens and samples were pseudonymized, no informed consent was obtained.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brückner, V., Fiebiger, U., Ignatius, R. et al. Characterization of Arcobacter strains isolated from human stool samples: results from the prospective German prevalence study Arcopath. Gut Pathog 12, 3 (2020).

Download citation


  • Arcobacter
  • Human
  • Cytotoxicity
  • Virulence genes
  • Genotyping